BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 12969990)

  • 1. Harmful effects of increased LDLR expression in mice with human APOE*4 but not APOE*3.
    Malloy SI; Altenburg MK; Knouff C; Lanningham-Foster L; Parks JS; Maeda N
    Arterioscler Thromb Vasc Biol; 2004 Jan; 24(1):91-7. PubMed ID: 12969990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in Recycling of Apolipoprotein E3 and E4-LDL Receptor Complexes-A Mechanistic Hypothesis.
    Kim M; Bezprozvanny I
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34068576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic modifiers of atherosclerosis in mice.
    Knowles JW; Maeda N
    Arterioscler Thromb Vasc Biol; 2000 Nov; 20(11):2336-45. PubMed ID: 11073835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deconvolving Passive and Active Targeting of Liposomes Bearing LDL Receptor Binding Peptides Using the Zebrafish Embryo Model.
    Bi D; Van Hal A; Aschmann D; Shen M; Zhang H; Su L; Arias-Alpizar G; Kros A; Barz M; Bussmann J
    Small; 2024 Mar; ():e2310781. PubMed ID: 38488770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 27-Hydroxycholesterol-Induced Dysregulation of Cholesterol Metabolism Impairs Learning and Memory Ability in ApoE ε4 Transgenic Mice.
    Wang Y; Hao L; Wang T; Liu W; Wang L; Ju M; Feng W; Xiao R
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36232940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein E in Cardiometabolic and Neurological Health and Diseases.
    Alagarsamy J; Jaeschke A; Hui DY
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integration of Transformative Platforms for the Discovery of Causative Genes in Cardiovascular Diseases.
    Lu H; Zhang J; Chen YE; Garcia-Barrio MT
    Cardiovasc Drugs Ther; 2021 Jun; 35(3):637-654. PubMed ID: 33856594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized trial and novel SPR technique identifies altered lipoprotein-LDL receptor binding as a mechanism underlying elevated LDL-cholesterol in APOE4s.
    Calabuig-Navarro MV; Jackson KG; Kemp CF; Leake DS; Walden CM; Lovegrove JA; Minihane AM
    Sci Rep; 2017 Mar; 7():44119. PubMed ID: 28276521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ApoE knockout and knockin mice: the history of their contribution to the understanding of atherogenesis.
    Getz GS; Reardon CA
    J Lipid Res; 2016 May; 57(5):758-66. PubMed ID: 27015743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein E-low density lipoprotein receptor interaction affects spatial memory retention and brain ApoE levels in an isoform-dependent manner.
    Johnson LA; Olsen RH; Merkens LS; DeBarber A; Steiner RD; Sullivan PM; Maeda N; Raber J
    Neurobiol Dis; 2014 Apr; 64():150-62. PubMed ID: 24412220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetic atherosclerosis in APOE*4 mice: synergy between lipoprotein metabolism and vascular inflammation.
    Johnson LA; Kim HS; Knudson MJ; Nipp CT; Yi X; Maeda N
    J Lipid Res; 2013 Feb; 54(2):386-96. PubMed ID: 23204275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pro- and antiatherogenic effects of a dominant-negative P465L mutation of peroxisome proliferator-activated receptor-γ in apolipoprotein E-Null mice.
    Pendse AA; Johnson LA; Kim HS; McNair M; Nipp CT; Wilhelm C; Maeda N
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1436-44. PubMed ID: 22539598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein E4 domain interaction accelerates diet-induced atherosclerosis in hypomorphic Arg-61 apoe mice.
    Eberlé D; Kim RY; Luk FS; de Mochel NS; Gaudreault N; Olivas VR; Kumar N; Posada JM; Birkeland AC; Rapp JH; Raffai RL
    Arterioscler Thromb Vasc Biol; 2012 May; 32(5):1116-23. PubMed ID: 22441102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms and genetic determinants regulating sterol absorption, circulating LDL levels, and sterol elimination: implications for classification and disease risk.
    Calandra S; Tarugi P; Speedy HE; Dean AF; Bertolini S; Shoulders CC
    J Lipid Res; 2011 Nov; 52(11):1885-926. PubMed ID: 21862702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of apolipoprotein E-deficient mice.
    Maeda N
    Arterioscler Thromb Vasc Biol; 2011 Sep; 31(9):1957-62. PubMed ID: 21849705
    [No Abstract]   [Full Text] [Related]  

  • 16. Apolipoprotein E4 exaggerates diabetic dyslipidemia and atherosclerosis in mice lacking the LDL receptor.
    Johnson LA; Arbones-Mainar JM; Fox RG; Pendse AA; Altenburg MK; Kim HS; Maeda N
    Diabetes; 2011 Sep; 60(9):2285-94. PubMed ID: 21810592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the human apoE2 isoform in adipocytes: altered cellular processing and impaired adipocyte lipogenesis.
    Huang ZH; Maeda N; Mazzone T
    J Lipid Res; 2011 Sep; 52(9):1733-41. PubMed ID: 21743035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired adipogenic response to thiazolidinediones in mice expressing human apolipoproteinE4.
    Arbones-Mainar JM; Johnson LA; Altenburg MK; Kim HS; Maeda N
    FASEB J; 2010 Oct; 24(10):3809-18. PubMed ID: 20501792
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.